Shrikant Akolkar
Stock Analyst at Nuvama
(2.27)
# 2,971
Out of 4,355 analysts
8
Total ratings
50%
Success rate
6.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Shrikant Akolkar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: CIPLA Cipla Limited | Maintained: Sell | n/a | $1,401.00 | - | 3 | Jan 27, 2026 | |
| NSE: AUROPHARMA Aurobindo Pharma Limited | Maintained: Buy | ₹1,485 → ₹1,460 | $1,426.40 | +2.36% | 2 | Jun 27, 2025 | |
| NSE: JUBLPHARMA Jubilant Pharmova Limited | Maintained: Buy | ₹1,385 | $995.00 | +39.20% | 1 | Jun 27, 2025 | |
| NSE: LUPIN Lupin Limited | Maintained: Buy | ₹2,530 | $2,267.70 | +11.57% | 1 | Jun 27, 2025 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Upgraded: Buy | ₹1,553 | $1,303.50 | n/a | 1 | Jan 7, 2025 |
Cipla Limited
Jan 27, 2026
Maintained: Sell
Price Target: n/a
Current: $1,401.00
Upside: -
Aurobindo Pharma Limited
Jun 27, 2025
Maintained: Buy
Price Target: ₹1,485 → ₹1,460
Current: $1,426.40
Upside: +2.36%
Jubilant Pharmova Limited
Jun 27, 2025
Maintained: Buy
Price Target: ₹1,385
Current: $995.00
Upside: +39.20%
Lupin Limited
Jun 27, 2025
Maintained: Buy
Price Target: ₹2,530
Current: $2,267.70
Upside: +11.57%
Dr. Reddy's Laboratories Limited
Jan 7, 2025
Upgraded: Buy
Price Target: ₹1,553
Current: $1,303.50
Upside: n/a